Cookson Peirce & Co’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Cookson Peirce & Co’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,160	Closed	-$415K	–	143
2018 Q1	$415K	Buy	4,160 +100	+2%	+$10.8K	0.04%	121
2017 Q4	$381K	Buy	4,060 +565	+16%	+$53.4K	0.04%	136
2017 Q3	$356K	Buy	3,495 +450	+15%	+$39.3K	0.04%	131
2017 Q2	$233K	Buy	3,045 +20	+0.7%	+$1.68K	0.03%	140
2017 Q1	$261K	Buy	+3,025	New	+$218K	0.03%	133

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cookson Peirce & Co's LKFT Position: Q2 2018 in Review

Cookson Peirce & Co sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2018, closing a stake of 4,160 shares — an estimated $415K sold.

Cookson Peirce & Co first reported a position in LKFT in Q1 2017 and held it in 5 quarters. The position peaked at $415K in Q1 2018. 79 funds tracked by Wall St. Rank hold LKFT as of Q2 2018.

Cookson Peirce & Co reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2018 after selling out during the quarter.
Cookson Peirce & Co sold 4,160 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2018, an estimated $415K.
Cookson Peirce & Co first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2017 and held it in 5 quarters.
Cookson Peirce & Co's Lakefront Biotherapeutics American Depositary Shares position peaked at $415K in Q1 2018.
79 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2018.

Based on Cookson Peirce & Co's 13F filing for Q2 2018, filed 26 Jul 2018.